Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income (loss)	$ 11,983	$ (77,685)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Depreciation and amortization	11,411	12,519
Provision for doubtful accounts	2,768	(481)
Gain on extinguishment of debt	(34)	(4,891)
Loss on divestiture of business	0	5,331
Change in fair value of private warrant liability	3,610	(1,026)
Change in fair value of derivatives	(19,526)	6,724
Stock-based compensation	12,910	12,473
Non-cash interest expense	17,515	17,313
Gain on settlement of contingent consideration	0	(14,930)
Other operating activities	(829)	(2,182)
Change in operating assets and liabilities, net of acquisitions and divestitures
Accounts receivable	(2,039)	(1,548)
Reinsurance balance due	46,760	(20,042)
Deferred policy acquisition costs	7,939	10,895
Accounts payable	(336)	(5,627)
Accrued expenses and other current liabilities	(4,440)	(7,827)
Losses and loss adjustment expense reserves	283	37,717
Other insurance liabilities, current	(9,182)	35,615
Deferred revenue	(51,528)	(25,693)
Refundable customer deposits	869	(3,594)
Other assets and liabilities, net	(3,743)	9,434
Net cash provided by (used in) operating activities	24,391	(17,505)
Cash flows from investing activities:
Purchases of property and equipment	(271)	(86)
Capitalized internal use software development costs	(6,756)	(5,458)
Purchases of short-term and long-term investments	(75,423)	(19,193)
Maturities, sales of short-term and long-term investments	57,181	22,631
Proceeds from sale of business	0	10,870
Net cash provided by (used in) investing activities	(25,269)	8,764
Cash flows from financing activities:
Proceeds from issuance of debt	51,000	0
Repayments of principal	(55,858)	(3,150)
Cash paid for debt issuance costs	(2,206)	0
Other financing activities	(947)	24
Net cash used in financing activities	(8,011)	(3,126)
Net change in cash, cash equivalents, and restricted cash and cash equivalents	(8,889)	(11,867)
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	196,782	297,232
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	187,893	285,365
Supplemental schedule of non-cash investing and financing activities
Non-cash reduction of convertible notes, net	14,514	5,000
Non-cash reduction in advance funding arrangement obligations	0	94
Supplemental disclosures
Cash paid for interest	12,021	12,056
Income taxes paid	$ 349	$ 538